Thursday, Aug 22, 2024 · SEC filings
What the smart money revealed on Aug 22
435 insider filings came in. We hid 88 planned (10b5-1) sellers and 151 people whose filings were routine, like grants and tax withholding.
CNX Resources (CNX) Director Bernard Lanigan Jr. bought $2.01M
75,000 shares on the open market. Not a grant or an option exercise.
Golub Capital BDC (GBDC) CEO David Golub bought $595K
40,000 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 3 checked quarters beat the typical stock 6 months later.
Inhibrx Biosciences (INBX) CEO Mark Lappe bought $518K
40,000 shares on the open market. Not a grant or an option exercise.
Core Scientific (CORZ) Director Jordan Levy bought $497K
48,700 shares on the open market. Not a grant or an option exercise.
SS&C Technologies (SSNC) President and COO Rahul Kanwar sold $36.5M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 57,642 shares directly.
Palantir Technologies (PLTR) Officer Stephen Cohen sold $11.1M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 592 shares directly.
Baldwin Insurance Group (BWIN) Director Lowry Baldwin sold $3.42M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 33 more real buys
Show 131 more real sales
13F season
Holdings as of Jun 30, 2024 were due Aug 14
54 funds have filed. 50 filed for the quarter before.
Biggest real insider buys, Aug 16–22
Open-market buys by officers and directors, filed in the 7 days up to Aug 22.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.